Early Feasibility Study of 3830 Lead Implantation Via the Middle Cardiac Vein in Patients With Prior or Planned Tricuspid Valve Intervention

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Prospective, single center, early feasibility study designed to evaluate the initial safety and device performance of the Medtronic 3830 Lead when implanted via the Middle Cardiac Vein in patients with prior or planned tricuspid valve interventions.
Epistemonikos ID: 41ffd0a6e3bc289e68f46639701bbf97e5ec86dc
First added on: Sep 05, 2026